Experimental ageing research: From false knowledge to true ignorance;Investigación experimental sobre envejecimiento: Del falso conocimiento a la verdadera ignorancia

Revista Espanola de Geriatria y Gerontologia

Volumn 39, Issue 5, 2004, Pages 320-328

  Anisimov, V N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Current gerontology; Longevity genes; Oxidative stress ageing

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CATALASE; COLLAGEN; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; GLUTATHIONE TRANSFERASE; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P66; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TELOMERASE; THIOREDOXIN; URIC ACID; XANTHINE DEHYDROGENASE;

AGING; CANCER; CELL AGING; DROSOPHILA MELANOGASTER; GENE EXPRESSION; GERONTOLOGICAL RESEARCH; HUMAN; LONGEVITY; NONHUMAN; OXIDATIVE STRESS; PINEAL BODY; REVIEW; TELOMERE; YEAST;

EID: 6344261850     PISSN: 0211139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0211-139x(04)74981-1     Document Type: Review

References (91)

1. Finch CE, Ruvkun G. The genetics of aging. Ann Rev Genomics Hum Genet 2001;2:435-62.
2. Butler RN, Fossel M, Harman SM, et al. Is there an antiaging medicine? J Gerontol Biol Sci 2002;57A:B333-8.
3. Hasty P, Campisi J, Hoeijmakers J, et al. Aging and genome maintenance: lessons from the mouse? Science 2003;299:1355-9.
4. Anisimov VN. Aging and cancer in transgenic and mutant mice. Front Biosci 2003;8:S883-902.
5. Liang H, Masoro EJ, Nelson JF, et al. Genetic mouse models of extended lifespan. Exp Gerontol 2003;38:1353-64.
6. Anisimov VN. Carcinogenesis and aging. Vols 1 and 2. Boca Raton: CRC Press, 1987.
7. Anisimov VN. The relationship between aging and carcinogenesis. Crit Rev Oncol Hematol 2003;45:277-304.
8. Ames BN, Shigenaga MB, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915-22.
9. Harman D. Extending functional life span. Exp Gerontol 1998;33:95-112.
10. Skulachev VP. The programmed death phenomena, aging, and the Samurai law of biology. Exp Gerontol 2001;36:995-1024.
11. Cutler R. Oxidative stress: its potential relevance to human disease and longevity determinants. Age 1995;18:91-6.
12. Arking R, Force AG, Dugas SP, et al. Factors contributing to the plasticity of the extended longevity phenotypes of Drosophila. Exp Gerontol 1996;31:623-43.
13. Orr WC, Sohal RS. Extension of life-span by overexpresion of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994;263:1128-30.
14. Parkes TL, Elia AJ, Dickinson D, et al. Extension of Drosophila lifespan by overexpression of human SOD1 in motoneurons. Nature Genetics 1998;19:171-4.
15. Melov S, Ravenscroft J, Malik S, et al. Extension of life-span with superoxide dismutase/catalase mimetics. Science 2000;289:1567-9.
16. Huang TT, Carlson EJ, Gillespie AM, et al. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J Gerontol A Biol Sci Med Sci 2000;55:B5-9.
17. Babich H. Butylated hydroxytoluene (BHT): a review. Environ Res 1982;29:1-29.
18. Ito N, Hirose M. The role of antioxidants in chemical carcinogenesis. Jpn J Cancer Res 1987;78:1011-26.
19. Manson MM, Green JA, Driver HE. Ethoxyquin alone inducespreneoplastic changes in rat kidney whilst preventing induction of such lesions in liver by aflatoxin B(1). Carcinogenesis 1987;8:723-8.
20. Porta EA, Joun NS, Nitta RT. Effect of the type of dietary fat at two levels of vitamin E in Wistar male rats during development and aging. I. Life span, serum biochemical parameters and pathological changes. Mech Ageing Dev 1980;13:1-39.
21. Toth B, Patil K. Enhancing effect of vitamin E on murine intestinal tumorigenesis by 1,2-dimethylhydrazine dihydrochloride. J Natl Cancer Inst 1983;70:1107-11.
22. Ohshima M, Ward JM, Wenk ML. Preventive and enhancing effects of retinoids on the development of naturally occuring tumors of skin, prostate gland, and endocrine pancreas in aged male ACI/segHapBR rats. J Natl Cancer Inst 1985;74:517-24.
23. Schroeder HA, Mitchener M. Selenium and tellurium in rats: effect on growth, survival and tumors. J Nutr 1971;101:1531-40.
24. Cherkes LA, Aptekar SG, Volgarev MN. Liver tumors induced by selenium. Bull Exp Biol Med 1962;53:78-83.
25. McCall MR, Frei B. Can antioxidant vitamins meterially reduce oxidative damage in humans? Free Radical Biol Med 1999;26:1034-53.
26. Bartke A, Chandrashekar V, Dominici F, et al. Insulin-like growth factor 1 (IGF01) and aging: controvrses and new insights. Biogerontology 2003;4:1-8.
27. Tatar M, Bartke A, Antebi A. The endocrine regulation of afging by insulin-like signals. Science 2003;299:1346-51.
28. Facchini FS, Hua NW, Reaven GM, Stoohs RA. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radicals Biol Med 2000;29:1302-6.
29. Dilman VM. Development, aging and disease. A new rationale for an intervention. Harwood Academic Publ, Chur, 1994.
30. Barbieri M, Rizzo MR, Manzella D, et al. Glucose regulation and oxidative stress in healthy centenarians. Exp Gerontol 2003;38:137-43.
31. Colangelo LA, Gapstur SM, Gann PH. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002;11:385-91.
32. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am J Med Sci 2002;323:140-5.
33. Longo VD, Finch CE. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 2003;299:1342-6.
34. Masoro EJ. Subfield history: caloric restriction, slowing aging, and extending life. Science's SAGE KE, 2003, ns2 [consultado 26/7/2003]. Disponible e: http://Sageke.sciencemag. org/cgi/content/full/sageke;2003/8/re2.
35. Hadley EC, Dutta C, Finkelstein J, et al. Human implications of caloric restriction's effect on laboratory animals: an overview of opportunities for research. J Gerontol Ser A 2001;56A(Special issue 1):5-6.
36. Weindruch R, Keenan KP, Carney JM, et al. Caloric restriction mimetics: metabolic intervention. J Gerontol Biol Sci 2001;56A(Special Issue 1):20-33.
37. Muntoni S. Metformin and fatty acids. Diabetes Care 1999;22:179-80.
38. Berstein LM, Evtushenko TP, Tsyrlina EV, et al. Comparative study of 5- and 10-year-long results of the metabolic rehabilitation of cancer patients. En: Hanson KP, Dilman VM, editors. Neuroendocrine system, metabolism, immunity and cancer (clinical aspects). St. Petersburg: NN Petrov Research Institute of Oncology Publ, 1992; p. 102-12.
39. Bakaev W. Effect of 1-butylbiguanide hydrochloride on the longevity in the nematoda Caenorhabditis elegans. Biogerontology 2002;3(Suppl 1):23-4.
40. Anisimov VN, Semenchenko AV, Yashin AI. Insulin and longevity: antidiobetic biguanides as geroprotectors. Biogerontology 2003;4:297-307.
41. Awortani KA, Cheung AP. Metformin and polycystic ovary syndrome: a literature review. J Obstet Gynecol Can 2002;24:393-401.
42. Fernandes ML, Saad MJ, Velloso LA. Effect of age on elements of insulin-signaling pathway in central nervous system of rats. Endocrine 2001;16:227-34.
43. Richards JS, Russell DL, Ochsner S, et al. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 2002;57:195-220.
44. Chiba T, Yamaza H, Higami Y, Shimokawa I. Anti-aging effects of caloric restriction: Involvement of neuroendocrine adaptation by peripheral signaling. Microsc Res Tech 2002;59:317-24.
45. Mattson MP, Duan W, Maswood N. How does the brain control lifespan? Ageing Res Rev 2002;1:155-65.
46. Anisimov VN. Insulin: IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention. Exp Gerontol 2003;38:1041-9.
47. Gargiulo P, Caccese D, Pignatelli P, et al. Metformin decreases platelet superoxide anion production in diabetic patients. Diabetes Metab Res Rev 2002;18:156-9.
48. Campisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol 2003;38:5-11.
49. Maciera-Coelho A. Neoplastic disease through the human life span. Biogerontology 2001;2:179-92.
50. Maciera-Coelho A. Genome reorganization through cell division, implications for aging of the organism and cancer development. Ann NY Acad Sci 1994;719:108-28.
51. Tavoloni N, Inoue H. Cellular aging is a critical determinant of primary cell resistance to v-src transformation. J Virol 1997;71:237-47.
52. Kunisada T, Danner D, Friedman V, Schneider EL. Incerased susceptibility to SV40 transformation with development and in vitro aging. Exp Cell Res 1990;189:222-6.
53. Bringold F, Serrano M. Tumor supressors and oncogenes in cellular senescence. Exp Gerontol 2000;35:317-29.
54. Shay JW, Wright WE, Werbin H. Loss of telomeric DMA during aging may predispose cells to cancer. Int J Oncology 1993;3:559-63.
55. Reddel RR. A reassessment of the telomere hypothesis of senescence. Bioessays 1998;20:977-84.
56. Blagosklonny MV. How carcinogens (or telomere dysfunction) induce genetic instability: associated-selection model. FEBS Lett 2001;506:169-72.
57. Wynford-Thomas D, Bond JA, Wyllie FS, Jones CJ. Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinogenesis 1995;12:119-23.
58. Krtolica A, Parinello S, Locckett S, et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001;98:12072-7.
59. Rinehart CA, Torti VR. Aging and cancer: the role of stromal interactions with epithelial cells. Mol Carcinogenesis 1997;18:187-92.
60. Mathon NF, Malcolm DS, Harrisingh MC, et al. Lack of replicative senescence in normal rodent glia. Science 2001;291:872-5.
61. Tang DG, Tokumoto YM, Apperly JA, et al. Lack of replicative senescence in cultured rat oligodendrocyte precursor cell. Science 2001;291:868-71.
62. Romanov SR, Kozakiewicz BK, Holst CR, et al. Normal human mammary epithelial cells spontaneously escape senescence and aquire genomic changes. Nature 2001;409:633-7.
63. Clevenger CV. A old epithelial cell never dies, it just agonesces away. Trends Endocrinol Metab 2001;12:183-4.
64. Rha SY. Changes of telomerase and telomere length in paried normal and cancer tissues of breast. Int J Oncol 1999;15:839-45.
65. Anisimov VN, Zhukovskaya NV, Loktionov AS, et al. Influence of host age on lung colony forming capacity of injected rat rhabdomyosarcoma cells. Cancer Lett 1988;40:77-82.
66. McCullough KD, Coleman WB, Smith GJ, Grisham JW. Age-dependent regulation of the tumorigenic potential of neoplastically transformed rat liver epithelial cells by the liver microenvironment. Cancer Res 1994;54:3668-71.
67. Arendt J. Melatonin and the Mammalian Pineal Gland. London: Chapman & Hall, 1995.
68. Pevet P, Bothorel B, Slotten H, Saboureau M. The chronobiotic properties of melatonin. Cell Tissue Res 2002;309:183-91.
69. Touitou Y. Human aging and melotonin. Clinical relevance. Exp Gerontol 2001;36:1083-100.
70. Malm OJ, Skaug OE, Lingjoerde P. The effect of pinealectomy on bodily growth. Acta Endocrinol 1959;30:22-8.
71. Reiter RJ, Tan DX, Kim SJ, et al. Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mech Ageing Dev 1999;110:157-73.
72. Pierpaoli W, Regelson W. Pineal control of aging: effect of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci USA 1994;91:787-91.
73. Lesnikov VA, Pierpaoli W. Pineal cross-transplantation (old-to-young and vice versa) as evidence for an endogenous «aging clock». Ann NY Acad Sci 1994;719:461-73.
74. Anisimov VN. Effects of exogenous melatonin: a review. Toxicol Pathol 2003b;31:589-603.
75. Cos S, Sánchez-Barceló EJ. Melatonin and mammary pathological growth. Front Neuroendocrin 2000;17:133-70.
76. Deerberg F, Bartsch C, Pohlmeyer G, Bartsch H. Effect of melatonin and physiological epiphysectomy on the developmet of spontaneous endometrial carcinoma in BDII/HAN rats. Cancer Biother Radiopharmacol 1997;12:420.
77. Anisimov VN, Popovich IG, Zabezhinski MA. Melatonin and colon carcinogenesis: I. Inhibitory effects of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 1997;18:1549-53.
78. Anisimov VN, Zabezhinski MA, Popovich IG, et al. Inhibitory effect of melatonin on 7,12-dimethylbenz[a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro. Cancer Lett 2000;156:199-205.
79. Imaida K, Hagiwara A, Yoshino H, et al. Inhibitory effects of low doses of melatonin on induction of preneoplastic liver lesions in a medium-term liver bioassay in F344 rats: relation to the influence of electromagnetic near field exposure. Cancer Lett 2000;155:105-14.
80. Lissoni P. Is there a role for melatonin in supportive care? Support Care Cancer 2002;10:110-6.
81. Bellipanni G, Bianchi P, Pierpaoli W, et al. Effects of melatonin in perimenopausal and menopousal women: a randomized and placebo controlled study. Exp Gerontol 2001;36:297-310.
82. US General Accounting Office. Anti-aging products pose potential for physical and economic harm. Special Committee on Aging, GAO-01-1129, September 2001. Disponible en: htip://aging.senate.gov/hr73gao.pdf
83. Anisimov VN. Life span extension and cancer risk: myths and reality. Exp Geront 2001;36:1101-36.
84. Chen JB, Sun J, Jazwinski SM. Prolongation of the yeast life span by the v-Ha-RAS oncogene. Mol Microbiol 1990;4:2081-6.
85. Lin YJ, Seroude L, Benzer S. Extended life-span and stress resistance in the Drosophila mutant methuselah. Science 1998;282:943-6.
86. Morris JZ, Tissenbaum HA, Ruvkun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 1996;382:536-9.
87. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, an insulin receptor-like gene that regulated longevity and diapause in Caenorhabditis elegans. Science 1997;277:942-6.
88. Mitsui A, Hamuro J, Nakamura R, et al. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 2002;4:693-6.
89. Migliaccio E, Giorgio M, Mele S, et al. The p66shr adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309-13.
90. Holzenberger M, Dupond J, Ducos B, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003;421: 182-7.
91. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life span by introduction of telomerase into normal human cells. Sciences 1998; 279:349-52.